Wednesday, October 04, 2006

Northfield Laboratories Inc. Q1 '07 earnings

Conference call for first quarter 2007 earnings -Wednesday, October 11, 2006, at 11:00 a.m. Eastern Time linked here.

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. PolyHeme® is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life in excess of 12 months.

Photograph credit Northfield Laboratories Inc.

No comments:

Personal Blogs - Blog Top Sites